The FSH Society is hosting a workshop to addresses clinical trial readiness for facioscapulohumeral muscular dystrophy (FSHD). Because of your interest in FSHD, we are inviting representatives from your company to participate. We’re asking that you consider the focus on drug development tools and select no more than three representatives from your company with appropriate expertise (preclinical, clinical, or commercial development) to contribute to these discussions. Please register the names of representatives to the workshop by November 9, 2018.
Industry Collaborative on Drug Development
Tuesday, March 12, 2019
9:00 am to 5:00 pm
Tommy Douglas Conference Center, Silver Spring, MD
By invitation only